In this installment of “Expert Picks,” Manasi Agrawal, MD, of the Ichan School of Medicine at Mount Sinai, highlights four abstracts on inflammatory bowel disease from the 2020 virtual United European Gastroenterology Week.
Abstract OP014. Vedolizumab levels in mothers and newborns, clearance in neonates, susceptibility to infection, and achievement of developmental milestones (Julsgaard et al)
Researchers at 12 hospitals in Canada and Denmark prospectively analyzed data